Non-prescription drug issues. Monograph reauthorization. Rx to OTC switch. HSA/FSA.
2025 · 1st Quarter (Jan 1 - Mar 31)
CHATTEM, INC D/B/A OPELLA
Filed by CHATTEM, INC D/B/A OPELLA.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 17, 2025
- Income
- Not reported
- Expenses
- $230,000.00
- Registrant
- CHATTEM, INC D/B/A OPELLA
- Filing UUID
- a6f1fe21-99c2-4e91-934d-a7470e7bb6a3
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.